Subscribe to Legal

The Lead

Federal Charges Filed Against New Jersey Drug Company

February 27, 2015 8:17 am | by Andy Szal, Digital Reporter | News | Comments

Federal prosecutors have indicted a New Jersey compounding pharmacy and top company officials on 37 charges, including wire fraud and violations of federal drug safety laws.

Court: J&J Must Pay South Carolina $136M for Deceptive Drug Marketing

February 27, 2015 8:00 am | by MEG KINNARD, Associated Press | News | Comments

South Carolina's high court says a Johnson & Johnson subsidiary should pay the state $136...

Lawsuit Alleges Beneful Dog Food Killed Pets

February 26, 2015 8:39 am | Videos | Comments

Nestle Purina, the maker of Beneful, denies the claims in the lawsuit and says similar class-...

NY AG Expands Herbal Supplements Investigation

February 24, 2015 8:25 am | by MARY ESCH, Associated Press | News | Comments

Three weeks after ordering four major retailers to pull store-brand herbal supplements off their...

View Sample

FREE Email Newsletter

Tobacco Companies Fighting Over Claims on Smoking's Effects

February 23, 2015 11:31 am | News | Comments

America's biggest tobacco companies say they are ready and willing to pass along factual public health information about cigarettes. But they say they will not go along with being forced to underwrite an ad campaign that would have the companies brand themselves as liars.

Merck Ex-Financial Analyst Pleads Guilty in Insider Trading Case

February 20, 2015 8:07 am | News | Comments

Zachary Zwerko pleaded guilty in Manhattan federal court to conspiring to commit securities fraud and three securities fraud counts. A plea agreement recommended a three to four-year prison sentence.

Boston Scientific to Pay Johnson & Johnson $600M

February 18, 2015 8:13 am | News | Comments

Boston Scientific will pay $600 million to settle with drugmaker Johnson & Johnson over the medical device maker's $27 billion acquisition of Guidant Corp. in 2006.


US District Court Decision in PULMICORT RESPULES® Patent Litigation

February 17, 2015 8:44 am | News | Comments

AstraZeneca has announced that the US District Court for the District of New Jersey ruled US Patent No. 7,524,834 (“the ‘834 patent”), protecting PULMICORT RESPULES in the US, is invalid.

Are Health Companies Unprepared for Hack Attacks?

February 12, 2015 8:55 am | Videos | Comments

The hacking attack that claimed information on 80 million Anthem customers is raising concerns on health companies' security preparedness.

AstraZeneca to Pay $7.9M Over Kickback Allegations

February 11, 2015 1:38 pm | News | Comments

The Justice Department says AstraZeneca will pay $7.9 million to settle allegations it engaged in a kickback scheme involving drugs such as heartburn medicines Nexium and Prilosec.

U.S. Challenges Chinese Export Program

February 11, 2015 11:56 am | by Andrew Szal, Editor, Pharmaceutical Processing | News | Comments

The United States has accused the Chinese government of providing prohibited subsidies on a wide range of the country's exports, providing an unfair advantage in the marketplace and hindering American businesses.

Why Hackers Target Health Providers like Anthem Insurance

February 11, 2015 8:48 am | Videos | Comments

There are new questions about whether Anthem Insurance did enough to protect customers' date from cyber thieves. Chinese hackers may be behind the company's massive security breach that will affect tens of millions.


Supplements Industry Derides NY Attorney General's DNA Tests

February 9, 2015 7:47 am | by MARY ESCH, Associated Press | News | Comments

DNA barcoding has exposed some infamous cases of food fraud, like cheap catfish sold as pricey grouper and expensive "sheep's milk" cheese that was really made from cow's milk. But can it tell if a pill touted as an energy-booster contains ginseng or is just a mix of rice powder and pine?

Anthem Breach: A Gap in Federal Health Privacy Law?

February 9, 2015 7:32 am | by RICARDO ALONSO-ZALDIVAR, Associated Press | News | Comments

Insurers aren't required to encrypt consumers' data under a 1990s federal law that remains the foundation for health care privacy in the Internet age — an omission that seems striking in light of the major cyberattack against Anthem.    

Hackers See Rewarding Targets in Health Care Companies

February 6, 2015 8:16 am | by TOM MURPHY, AP Business Writer; BRANDON BAILEY, AP Business Writer | News | Comments

Health care is a treasure trove for criminals looking to steal reams of personal information, as the hacking of a database maintained by the second-largest U.S. health insurer proves. The latest breach at health insurer Anthem Inc. follows a year in which more than 10 million people were affected by health care data breaches.

Herbal Supplements Crackdown: Some Brands May Be Misleading

February 3, 2015 1:25 pm | Videos | Comments

An investigation by the New York State Attorney General's office alleges some store brands failed ingredient tests.                       

NY Attorney General Targets Popular Herbal Supplements

February 3, 2015 10:51 am | by MARY ESCH, Associated Press | News | Comments

Numerous store brand supplements aren't what their labels claim to be, an ongoing investigation of popular herbal supplements subjected to DNA testing has found, New York Attorney General Eric Schneiderman said Tuesday.     


Arizona Court Ruling Allows Drug Lawsuits Under Consumer Fraud Law

February 2, 2015 8:23 am | News | Comments

An Arizona court ruling gives new rights to consumers who want to sue drug manufacturers. A state Court of Appeals' ruling Thursday revived a woman's lawsuit against a pharmaceutical company under Arizona's consumer fraud law.     

Senator Warren to File Bill Targeting Top Pharma Companies

January 22, 2015 2:24 pm | by STEVE LeBLANC, Associated Press | News | Comments

Warren's bill would require that whenever drug companies enter into a settlement with the government over alleged wrongdoing, they must pay a portion of their annual profits over five years to support research at the NIH and the FDA.   

Fitch: SCOTUS Extends Patent Benefit for Teva; Generics Lose for Now

January 22, 2015 8:20 am | News | Comments

The Supreme Court (SCOTUS) decision that a federals appeals court wrongly overturned Teva Pharmaceutical's (Teva) Copaxone patent is a positive credit development for the drug maker, according to Fitch Ratings.       

Supreme Court Sides with Teva in Drug Dispute

January 21, 2015 8:11 am | by SAM HANANEL, Associated Press | News | Comments

The U.S. Supreme Court on Tuesday sided with Teva Pharmaceutical in the company's high-profile patent dispute with rival firms over the top-selling multiple sclerosis drug. The justices ruled 7-2 that a federal appeals court wrongly overturned five of Teva's patents for the drug Copaxone.

Survey: Healthcare and Life Science Companies Aware of But Not Prepared for Whistleblower Lawsuits

January 21, 2015 8:09 am | News | Comments

Many healthcare and life science companies are ill-prepared for federal "whistleblower" lawsuits under the False Claims Act despite their knowledge of the law and its potential consequences, according to a national survey sponsored by Foley Hoag LLP.

Federal Judge Approves Consent Decree with California Dietary Supplement Maker

January 19, 2015 12:11 pm | News | Comments

A California dietary supplement manufacturer was ordered by a federal court to stop selling its products until the company comes into compliance with the U.S. Food and Drug Administration’s dietary supplement manufacturing regulations and other requirements listed in the consent decree.

Five Quick Questions: Biosimilar Regulatory and Intellectual Property Issues

January 15, 2015 1:50 pm | by Andrew Szal, Editor, Pharmaceutical Processing | Articles | Comments

As biologic drugs like Humira and Enbrel become a larger and larger part of the pharmaceutical market, a new report from attorneys at Goodwin Procter says the introduction of lower-cost generic versions called “biosimilars” may be close at hand. 

Hemispherx Biopharma Awarded $770,852 by Federal Judge

January 15, 2015 10:59 am | News | Comments

Hemispherx Biopharma announced that after prevailing in a federal lawsuit brought against the company by Cato Capital, the United States District Court for the District of Delaware has ordered Cato to pay Hemispherx attorney’s fees and costs in the amount of $770,852.76.

Sunovion Pharmaceuticals Files Patent Infringement Lawsuits Regarding Latuda®

January 14, 2015 4:09 pm | News | Comments

Sunovion Pharmaceuticals has filed patent infringement lawsuits against Emcure Pharmaceuticals Limited, Emcure Pharmaceuticals USA, Inc., and InvaGen Pharmaceuticals Inc. regarding their submissions of Abbreviated New Drug Applications for generic copies of Latuda®.

$18M Seized from Massachusetts Compounding Pharmacy Accounts

January 7, 2015 8:38 am | News | Comments

Authorities have seized over $18M from the owners of a Massachusetts compounding pharmacy at the center of a 2012 meningitis outbreak that killed 64 people nationwide. Attorney Carmen Ortiz said the funds were seized from 13 different financial institutions as a result of seizure warrants unsealed Tuesday.

Judge Orders Actavis to Continue Distribution of Alzheimer's Drug

January 7, 2015 8:20 am | News | Comments

A federal appeals court has left intact a judge's order for drug manufacturer Actavis PLC to keep distributing its widely used Alzheimer's medication.                 

Safeway Fined Nearly $10M for Illegal Disposal of Waste - Including Pharmaceuticals

January 6, 2015 1:16 pm | News | Comments

The Safeway supermarket chain has been ordered to pay nearly $10M for illegally dumping batteries, electronics and pharmaceuticals in California landfills. Alameda County District Attorney Nancy O'Malley says the practice occurred at more than 500 Safeway, Vons, Pavilions and Pak 'n Save stores and distribution sites throughout California for more than seven years.

You may login with either your assigned username or your e-mail address.
The password field is case sensitive.